Expression of POT1 is Associated with Tumor Stage and Telomere Length in Gastric Carcinoma

Cancer Research

Volumn 64, Issue 2, 2004, Pages 523-529

  Kondo, Tomohiro ^a   Oue, Naohide ^a   Yoshida, Kazuhiro ^b   Mitani, Yoshitsugu ^a   Naka, Kazuhito ^c   Nakayama, Hirofumi ^a   Yasui, Wataru ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA; NUCLEIC ACID BINDING PROTEIN; POT1 PROTEIN; TELOMERASE; UNCLASSIFIED DRUG; ZIDOVUDINE;

3' UNTRANSLATED REGION; ANAPHASE; ARTICLE; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; ENZYME INHIBITION; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYBRIDIZATION; POT1 GENE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; TELOMERE;

3' UNTRANSLATED REGIONS; CELL LINE, TUMOR; DNA PRIMERS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM STAGING; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; TELOMERE; TELOMERE-BINDING PROTEINS;

EID: 1642556797     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-1196     Document Type: Article

References (53)

1. Makarov, V. L., Hirose, Y., and Langmore, J. P. Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell, 88: 657-666, 1997.
2. McElligott, R., and Wellinger, R. J. The terminal DNA structure of mammalian chromosomes. EMBO J., 16: 3705-3714, 1997.
3. Wright, W. E., Tesmer, V. M., Liao, M. L., and Shay, J. W. Normal human telomeres are not late replicating. Exp. Cell Res., 251: 492-499, 1999.
4. Hanish, J. P., Yanowitz, J. L., and de Lange, T. Stringent sequence requirements for the formation of human telomeres. Proc. Natl. Acad. Sci. USA, 91: 8861-8865, 1994.
5. Allsopp, R. C., and Harley, C. B. Evidence for a critical telomere length in senescent human fibroblasts. Exp. Cell Res., 219: 130-136, 1995.
6. Harley, C. B., and Villeponteau, B. Telomeres and telomerase in aging and cancer. Curr. Opin. Genet. Dev., 5: 249-255, 1995.
7. Romero, D. P., and Blackburn, E. H. A conserved secondary structure for telomerase RNA. Cell, 67: 343-353, 1991.
8. Lingner, J., Cooper, J. P., and Cech, T. R. Telomerase and DNA endreplication: no longer a lagging strand problem? Science (Wash. DC), 269: 1533-1534, 1995.
9. Linger, J., Hughes, T. R., Shevchenko, A., Mann, M., Lundbald, V., and Cech, T. R. Reverse transcriptase motifs in the catalytic subunit of telomerase. Science (Wash. DC), 277: 955-959, 1997.
10. Prowse, K. R., and Greider, C. W. Developmental and tissue-specific regulation of mouse telomerse and telomere length. Proc. Natl. Acad. Sci. USA, 92: 4818-4822, 1995.
11. Tahara, H., Kuniyasu, H., Yokosaki, H., Yasui, W., Shay, J. W., Ide, T., and Tahara, E. Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin. Cancer Res., 1: 1245-1251, 1995.
12. Yasui, W., Tahara, E., Tahara, H., Fujimoto, J., Naka, K., Nakayama, J., Ishikawa, F., Ide, T., and Tahara, E. Immunohistochemical detection of human telomerase reverse transcriptase in normal mucosa and precancerous lesion of the stomach. Jpn. J. Cancer Res., 90: 589-595, 1999.
13. Baumann, P., and Cech, T. R. Pot1, the putative telomere end-binding protein in fission yeast and humans. Science (Wash. DC), 292: 1171-1175, 2001.
14. Evans, S. K., and Lundblad, V. Est1 and Cdc13 as comediators of telomerase access. Science (Wash. DC), 286: 117-120, 1999.
15. Nugent, C. I., Hughes, T. R., Lue, N. F., and Lundblad, V. Cdc13p: a single-strand telomeric DNA-binding protein with a dual role in yeast telomere maintenance. Science (Wash. DC), 274: 249-252, 1996.
16. Blackburn, E. H. Switching and signaling at the telomere. Cell, 106: 661-673, 2001.
17. Baumamm, P., Podell, E., and Cech, T. R. Human Pot1 (protection of telomeres) protein: cytolocalization, gene structure, and alternative splicing. Mol. Cell. Biol., 22: 8079-8087, 2002.
18. Lei, M., Baumamm, P., and Cech, T. R. Cooperative binding of single-stranded telomeric DNA by the Pot1 protein of Schzosaccharomyces pombe. Biochemistry, 41: 14560-14568, 2002.
19. Strahl, C., and Blackburn, E. H. The effects of nucleoside analogs on telomerase and telomeres in Tetrahymena. Nucleic Acids Res., 22: 893-900, 1994.
20. Strahl, C., and Blackburn, E. H. Effect of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines. Mol. Cell. Biol., 16: 53-65, 1996.
21. Rha, S. Y., Izbicka, E., Lawrence, R., Davidson, K., Sun, D., Moyer, M. P., Roodman, G. D., Hurley, L., and Von Hoff, D. Effect of telomere and telomerase interactive agents on human tumor and normal cell lines. Clin. Cancer Res., 6: 987-989, 2000.
22. Mo, Y., Gan, Y., Song, S., Johnston, J., Xiao, X., Wientjes, M. G., and Au, J. L. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach. Cancer Res., 63: 579-585, 2003.
23. Lauren, P. The two histological main types of gastric carcinoma. Diffuse and so-called intestinal type carcinoma: an attempt at histological classification. Acta Pathol. Microbiol. Scand., 64: 31-49, 1965.
24. Sobin, L. H., and Wittekind, C. H. (eds.). TNM Classification of Malignant Tumors, Digestive System Tumours, Ed. 5, pp. 59-62. New York: Wiley-Liss, Inc., 1997.
25. Dionne, I., and Wellinger, R. J. Cell cycle-regulated generation of single-stranded G-rich DNA in the absence of telomerase. Proc. Natl. Acad. Sci. USA, 93: 13902-13907, 1996.
26. Rudolph, K. L., Millard, M., Bosenberg, M. W., and DePinho, R. A. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat. Genet., 28: 155-159, 2001.
27. δ2/3 cancer-prone mouse. Cell, 97: 515-525, 1999.
28. Gonzalez-Suarez, E., Samper, E., Flores, J. M., and Blasco, M. A. Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat. Genet., 26: 114-117, 2000.
29. Farazi, P. A., Glickman, J., Jiang, S., Yu, A., Rudolph, K. L., and DePinho, R. A. Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma. Cancer Res., 63: 5021-5027, 2003.
30. Maser, R. S., and DePinho, R. A. Connecting chromosomes, crisis, and cancer. Science (Wash. DC), 297: 565-569, 2002.
31. Artandi, S. E., and DePinho, R. A. Mice without telomerase: what can they teach us about human cancer? Nat. Med., 6: 852-855, 2000.
32. Gordon, K. E., Ireland, H., Roberts, M., Steeghs, K., McCaul, J. A., MacDonald, D. G., and Parkinson, E. K. High levels of telomere dysfunction bestow a selective disadvantage during the progression of human oral squamous cell carcinoma. Cancer Res., 63: 458-467, 2003.
33. Counter, C. M., Avilion, A. A. LeFeuvre, C. E., Stewart, N. G., Harley, C. B., and Bacchetti, S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J., 11: 1921-1929, 1992.
34. O'Sullivan, J. N., Bronner, M. P., Brentnall, T. A., Finley, J. C., Shen, W. T., Emerson, S., Emond, M. J., Gollahon, K. A., Moskovitz, A. H., Crispin, D. A., Potter, J. D., and Rabinovitch, P. S. Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat. Genet., 32: 280-284, 2002.
35. Meeker, A. K., Hicks, J. L., Platz, E. A., March, G. E., Bennett, C. J., Delannoy, M. J., and De Marzo, A. M. Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis. Cancer Res., 62: 6405-6409, 2002.
36. Van Heek, N. T., Meeker, A. K., Kern, S. E., Yeo, C. J., Lillemoe, K. D., Cameron, J. L., Offerhaus, G. L., Hicks, J. L., Wilentz, R. E., Goggins, M. G., De Marzo, A. M., Hruban, R. H., and Maitra, A. Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. Am. J. Pathol., 161: 1541-1547, 2002.
37. Chin, L., Artandi, S. E., Shen, Q., Tam, A., Lee, S. L., Gottlieb, G. J., Greider, C. W., and DePinho, R. A. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell, 97: 527-538, 1999.
38. Artandi, S. E., Chang, S., Lee, S. L., Alson, S., Gottlieb, G. J., Chin, L., and DePinho, R. A. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature (Lond.), 406: 641-645, 2000.
39. DePinho, R. A. The age of cancer. Nature (Lond.), 408: 248-254, 2000.
40. McClintock, B. The production of homozygous deficient tissues with mutant characteristics by means of the aberrant behavior of ring-shaped chromosomes. Genetics, 23: 315-376, 1938.
41. McClintock, B. The stability of broken ends of chromosomes in Zea mays. Genetics, 26: 234-282, 1940.
42. Gisselsson, D., Bjork, J., Hoglund, M., Mertens, F., Dal Cin, P., Akerman, M., and Mandahl, N. Abnormal nuclear shape in solid tumors reflects mitotic instability. Am. J. Pathol., 158: 199-206, 2001.
43. Gisselsson, D., Pettersson, L., Hoglund, M., Heidenblad, M., Gorunova, L., Wiegant, J., Mertens, F., Dal Cin, P., Mitelman, F., and Mandahl, N. Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. Proc. Natl. Acad. Sci. USA, 97: 5357-5362, 2000.
44. Montgomery, E., Wilentz, R. E., Argani, P., Fisher, C., Hruban, R. H., Kern, S. E., and Lengauer, C. Analysis of anaphase figures in routine histologic sections distinguishes chromosomally unstable from chromosomally stable malignancies. Cancer Biol. Ther., 2: 248-252, 2003.
45. Gisselsson, D., Jonson, T., Petersen, A., Strombeck, B., Dal Cin, P., Hoglund, M., Mitelman, F., Meters, F., and Mandahl, N. Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors. Proc. Natl. Acad. Sci. USA, 98: 12683-12688, 2001.
46. Saunders, W. S., Shuster, M., Huang, X., Gharaibeh, B., Enyenihi, A. H., Petersen, I., and Gollin, S. M. Chromosomal instability and cytoskeletal defects in oral cancer cells. Proc. Natl. Acad. Sci. USA, 97: 303-308, 2000.
47. Poupon, M. F., Smith, K. A., Chernova, O. B., Gilbert, C., and Stark, G. R. Inefficient growth arrest in response to dNTP starvation stimulates gene amplification through bridge-breakage-fusion cycles. Mol. Biol. Cell, 7: 345-354, 1996.
48. Smith, K. A., Gorman, P. A., Stark, M. B., Groves, R. P., and Stark, G. R. Distinctive chromosomal structures are formed very early in the amplification of CAD genes in Syrian hamster cells. Cell, 63: 1219-1227, 1990.
49. Hastie, N. D., and Allshire, R. C. Human telomeres: fusion and interstitial sites. Trends Genet., 5: 326-331, 1989.
50. Stewart, S. A., Ben-Porath, I., Carey, V. J., O'Connor, B. F., Hahn, W. C., and Weinberg, R. A. Erosion of the telomeric single-strand overhang at replicative senescence. Nat. Genet., 33: 492-496, 2003.
51. Loayza, D., and de Lange, T. POT1 as a terminal transducer of TRF1 telomere length control. Nature (Lond.), 423: 1013-1018, 2003.
52. Colgin, L. M., Baran, K., Baumann, P., Cech, T. R., and Reddel, R. R. Human POT1 facilitates telomere elongation by telomerase. Curr. Biol., 13: 942-946, 2003.
53. van Steensel, B., Smogorzewska, A., and de Lange, T. TRF2 protects human telomeres from end-to-end fusions. Cell, 92: 401-413, 1998.